An interventional study of Blood draw and Chest X-ray in Community Acquired Pneumonia, sponsored by Pfizer. Completed at 1 site in Poland. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2012-04-13.
Sponsored by Pfizer · Not applicable and Interventional
This study is an observational surveillance study to identify adults 50 years and older who present to a study healthcare facility with signs and symptoms of Community-Acquired Pneumonia.
2,044 studies on the registry are indexed under Pneumonia; 283 are open to participants now.
This study's enrollment of 5,172 is above the median of 106 across 1,247 interventional studies indexed under Pneumonia.
Browse Pneumonia studies →Pfizer is the lead sponsor of 3,244 studies on the registry; 139 are open to participants now.
Of its 582 completed or terminated interventional studies of FDA-regulated products, 381 (65%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Subjects with Community-Acquired Pneumonia
Procedure: Blood draw · Procedure: Chest X-ray · Procedure: urine specimen · Procedure: Nasopharyngeal swab · Procedure: sputum
culture for Streptococcus pneumoniae Frequency-1
Also known as: Blood stick
image of the lungs to assess changes consistent with pneumonia Frequency-1
Also known as: Picture of lungs
assay for the presence of Streptococcus pneumoniae Binax and UAD
Also known as: urine dipstick test
culture for Streptococcus pneumoniae Frequency-1
Also known as: swab from inside the nose and throat
culture for Streptococcus pneumoniae Frequency-1
Also known as: collection secretions produced during cough
Incidence rates of CAP in adults 50 years and older
Time frame: up to 120 days from enrollment
Frequency of bacterial agents associated with CAP, Case fatality and incidence rates of CAP number and characteristics of subjects from outpatient clinics, emergency rooms, and hospital in-patient departments
Time frame: up to 120 days from enrollment
This study is completed, as verified in Apr 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pfizer